BIOMAT Database Logo BIOMAT Database Logo

Immunological follow-up of renal allograft recipients treated with the BMA 031 (anti-TCR) monoclonal antibody. 1990

L Chatenoud, and C Ferran, and C Legendre, and R Kurrle, and H Kreis, and J F Bach
Inserm U 25, CNRS UA 122, Paris, France.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000888 Antibodies, Anti-Idiotypic Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies. Anti-Antibodies,Anti-Idiotype Antibodies,Antibodies, Internal Image,Antigamma Globulin Antibodies,Antiglobulins,Anti Antibodies,Anti-gamma Globulin Antibodies,Anti Idiotype Antibodies,Anti gamma Globulin Antibodies,Anti-Idiotypic Antibodies,Antibodies, Anti,Antibodies, Anti Idiotypic,Antibodies, Anti-Idiotype,Antibodies, Anti-gamma Globulin,Antibodies, Antigamma Globulin,Globulin Antibodies, Anti-gamma,Globulin Antibodies, Antigamma,Image Antibodies, Internal,Internal Image Antibodies
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

L Chatenoud, and C Ferran, and C Legendre, and R Kurrle, and H Kreis, and J F Bach
BMA 031--a TCR-specific monoclonal antibody for clinical application.
February 1989, Transplantation proceedings,
L Chatenoud, and C Ferran, and C Legendre, and R Kurrle, and H Kreis, and J F Bach
The immunological follow up of renal allograft recipients.
December 1972, Proceedings of the Royal Society of Medicine,
L Chatenoud, and C Ferran, and C Legendre, and R Kurrle, and H Kreis, and J F Bach
Immunological follow-up of 41 renal allograft recipients.
January 1976, Scandinavian journal of urology and nephrology,
L Chatenoud, and C Ferran, and C Legendre, and R Kurrle, and H Kreis, and J F Bach
First clinical experience with a new TCR/CD3-monoclonal antibody (BMA 031) in kidney transplant patients.
July 1988, Transplant international : official journal of the European Society for Organ Transplantation,
L Chatenoud, and C Ferran, and C Legendre, and R Kurrle, and H Kreis, and J F Bach
Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody.
August 1990, Surgery,
L Chatenoud, and C Ferran, and C Legendre, and R Kurrle, and H Kreis, and J F Bach
Long-term follow-up of cyclosporine-treated renal allograft recipients.
December 1988, Transplantation proceedings,
L Chatenoud, and C Ferran, and C Legendre, and R Kurrle, and H Kreis, and J F Bach
Clinicopathological evaluation of renal allograft treated with anti-CD25 monoclonal antibody.
January 2005, Clinical transplantation,
L Chatenoud, and C Ferran, and C Legendre, and R Kurrle, and H Kreis, and J F Bach
Immunologic follow-up renal allograft recipients.
December 1972, Transplantation proceedings,
L Chatenoud, and C Ferran, and C Legendre, and R Kurrle, and H Kreis, and J F Bach
Prophylactic use of the new monoclonal antibody BMA 031 in clinical kidney transplantation.
August 1990, Transplantation proceedings,
L Chatenoud, and C Ferran, and C Legendre, and R Kurrle, and H Kreis, and J F Bach
OKT4A monoclonal antibody immunosuppression of cynomolgus renal allograft recipients.
February 1991, Transplantation proceedings,
Copied contents to your clipboard!